Position in RIGL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$529,606
+$119,356 QoQ
Shares Held
13,538
-10.8% QoQ
Ownership
0.072%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#84
of 156 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RIGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AVIVA PLC holds $285,082,134 across 22 Biotechnology names. RIGL ranks #10 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
223,593 | $111,065,350 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
91,486 | $57,045,180 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
114,532 | $34,477,567 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
118,070 | $22,112,149 | |
| 5 | RPRX |
Royalty Pharma plc
|
359,125 | $20,136,138 | |
| 6 | INCY |
Incyte Corp
|
148,924 | $16,882,024 | |
| 7 | INSM |
INSMED Inc
|
144,131 | $15,367,247 | |
| 8 | LEGN |
Legend Biotech Corp
|
53,486 | $1,544,675 |
All Filings in RIGL
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $529,606 | 13,538 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $410,250 | 15,172 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $479,738 | 11,201 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $387,781 | 13,688 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $445,567 | 23,789 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $368,866 | 20,504 | Shares | Defined | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||